前立腺癌治療薬の世界市場に関する洞察と2028年までの予測Global Prostate Cancer Therapeutics Drugs Market Insights and Forecast to 2028 市場の分析と洞察。前立腺癌治療薬の世界市場 COVID-19の流行により、前立腺癌治療薬の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになる... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場の分析と洞察。前立腺癌治療薬の世界市場COVID-19の流行により、前立腺癌治療薬の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮すると、2021年に前立腺癌治療薬の世界市場の%を占めたホルモン療法は、2028年までに百万米ドルの価値を持ち、COVID-19以降の期間に修正された%のCAGRで成長すると予測されます。一方、病院薬局セグメントは、この予測期間を通して%CAGRに変更されています。 中国の前立腺癌治療薬の市場規模は2021年に100万米ドル、米国と欧州の前立腺癌治療薬はそれぞれ100万米ドル、100万米ドルと評価されています。2021年の米国の割合は%、中国と欧州はそれぞれ%、%で、中国の割合は2028年には%に達すると予測され、分析期間を通じてCAGRは%を推移しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。ヨーロッパの前立腺癌治療薬の展望については、ドイツは2028年までに100万米ドルに達し、予測期間中にCAGR %を推移すると予測されています。 前立腺癌治療薬の世界の主要メーカーは、ジョンソン・エンド・ジョンソン、ファイザー、アストラゼネカ、アムジェン、アッヴィ、バイエル、イプセン、サノフィ、遠藤製薬などです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。 世界の前立腺癌治療薬の範囲とセグメント 前立腺癌治療薬市場は、タイプ別、販売チャネル別に区分される。世界の前立腺癌治療薬市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年までのタイプ別および販売チャネル別の売上、収益、予測に焦点を当てています。 タイプ別セグメント ホルモン療法 化学療法 生物学的療法 標的療法 その他 販売チャネル別セグメント 病院薬局 小売店 オンライン販売 その他 会社別 ジョンソン・エンド・ジョンソン ファイザー株式会社 アストラゼネカ アムジェン社 アッヴィ(AbbVie, Inc バイエルAG イプセン グループ サノフィ 遠藤製薬 デンドレオン株式会社 地域別 北米 米国 カナダ 欧州 ドイツ フランス イギリス イタリア ロシア アジア太平洋地域 中国 日本 韓国 インド オーストラリア 中国 台湾 インドネシア タイ マレーシア 中南米 メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア UAE 目次1 Study Coverage1.1 Prostate Cancer Therapeutics Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Hormone Therapy 1.2.3 Chemotherapy 1.2.4 Biologic Therapy 1.2.5 Targeted Therapy 1.2.6 Other 1.3 Market by Sale Channel 1.3.1 Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Sales 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Prostate Cancer Therapeutics Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Prostate Cancer Therapeutics Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Prostate Cancer Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Prostate Cancer Therapeutics Drugs Sales by Region 2.4.1 Global Prostate Cancer Therapeutics Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Prostate Cancer Therapeutics Drugs by Region (2023-2028) 2.5 Global Prostate Cancer Therapeutics Drugs Revenue by Region 2.5.1 Global Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2022) 2.5.2 Global Prostate Cancer Therapeutics Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Prostate Cancer Therapeutics Drugs Sales by Manufacturers 3.1.1 Global Top Prostate Cancer Therapeutics Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prostate Cancer Therapeutics Drugs in 2021 3.2 Global Prostate Cancer Therapeutics Drugs Revenue by Manufacturers 3.2.1 Global Prostate Cancer Therapeutics Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Drugs Revenue in 2021 3.3 Global Prostate Cancer Therapeutics Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Prostate Cancer Therapeutics Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Prostate Cancer Therapeutics Drugs Sales by Type 4.1.1 Global Prostate Cancer Therapeutics Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Prostate Cancer Therapeutics Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028) 4.2 Global Prostate Cancer Therapeutics Drugs Revenue by Type 4.2.1 Global Prostate Cancer Therapeutics Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Prostate Cancer Therapeutics Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Prostate Cancer Therapeutics Drugs Price by Type 4.3.1 Global Prostate Cancer Therapeutics Drugs Price by Type (2017-2022) 4.3.2 Global Prostate Cancer Therapeutics Drugs Price Forecast by Type (2023-2028) 5 Market Size by Sale Channel 5.1 Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel 5.1.1 Global Prostate Cancer Therapeutics Drugs Historical Sales by Sale Channel (2017-2022) 5.1.2 Global Prostate Cancer Therapeutics Drugs Forecasted Sales by Sale Channel (2023-2028) 5.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2028) 5.2 Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel 5.2.1 Global Prostate Cancer Therapeutics Drugs Historical Revenue by Sale Channel (2017-2022) 5.2.2 Global Prostate Cancer Therapeutics Drugs Forecasted Revenue by Sale Channel (2023-2028) 5.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2017-2028) 5.3 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel 5.3.1 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2017-2022) 5.3.2 Global Prostate Cancer Therapeutics Drugs Price Forecast by Sale Channel (2023-2028) 6 North America 6.1 North America Prostate Cancer Therapeutics Drugs Market Size by Type 6.1.1 North America Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028) 6.1.2 North America Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028) 6.2 North America Prostate Cancer Therapeutics Drugs Market Size by Sale Channel 6.2.1 North America Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028) 6.2.2 North America Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028) 6.3 North America Prostate Cancer Therapeutics Drugs Market Size by Country 6.3.1 North America Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028) 6.3.2 North America Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Prostate Cancer Therapeutics Drugs Market Size by Type 7.1.1 Europe Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028) 7.1.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028) 7.2 Europe Prostate Cancer Therapeutics Drugs Market Size by Sale Channel 7.2.1 Europe Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028) 7.2.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028) 7.3 Europe Prostate Cancer Therapeutics Drugs Market Size by Country 7.3.1 Europe Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028) 7.3.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Type 8.1.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Sale Channel 8.2.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028) 8.2.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028) 8.3 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Region 8.3.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Prostate Cancer Therapeutics Drugs Market Size by Type 9.1.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028) 9.1.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028) 9.2 Latin America Prostate Cancer Therapeutics Drugs Market Size by Sale Channel 9.2.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028) 9.2.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028) 9.3 Latin America Prostate Cancer Therapeutics Drugs Market Size by Country 9.3.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028) 9.3.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Type 10.1.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Sale Channel 10.2.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028) 10.2.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028) 10.3 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Country 10.3.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Johnson & Johnson 11.1.1 Johnson & Johnson Corporation Information 11.1.2 Johnson & Johnson Overview 11.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Johnson & Johnson Recent Developments 11.2 Pfizer, Inc 11.2.1 Pfizer, Inc Corporation Information 11.2.2 Pfizer, Inc Overview 11.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Pfizer, Inc Recent Developments 11.3 AstraZeneca 11.3.1 AstraZeneca Corporation Information 11.3.2 AstraZeneca Overview 11.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 AstraZeneca Recent Developments 11.4 Amgen, Inc 11.4.1 Amgen, Inc Corporation Information 11.4.2 Amgen, Inc Overview 11.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Amgen, Inc Recent Developments 11.5 AbbVie, Inc 11.5.1 AbbVie, Inc Corporation Information 11.5.2 AbbVie, Inc Overview 11.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 AbbVie, Inc Recent Developments 11.6 Bayer AG 11.6.1 Bayer AG Corporation Information 11.6.2 Bayer AG Overview 11.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Bayer AG Recent Developments 11.7 Ipsen Group 11.7.1 Ipsen Group Corporation Information 11.7.2 Ipsen Group Overview 11.7.3 Ipsen Group Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Ipsen Group Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Ipsen Group Recent Developments 11.8 Sanofi 11.8.1 Sanofi Corporation Information 11.8.2 Sanofi Overview 11.8.3 Sanofi Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Sanofi Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Sanofi Recent Developments 11.9 Endo Pharmaceuticals 11.9.1 Endo Pharmaceuticals Corporation Information 11.9.2 Endo Pharmaceuticals Overview 11.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Endo Pharmaceuticals Recent Developments 11.10 Dendreon Corporation 11.10.1 Dendreon Corporation Corporation Information 11.10.2 Dendreon Corporation Overview 11.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Dendreon Corporation Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Prostate Cancer Therapeutics Drugs Industry Chain Analysis 12.2 Prostate Cancer Therapeutics Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Prostate Cancer Therapeutics Drugs Production Mode & Process 12.4 Prostate Cancer Therapeutics Drugs Sales and Marketing 12.4.1 Prostate Cancer Therapeutics Drugs Sales Channels 12.4.2 Prostate Cancer Therapeutics Drugs Distributors 12.5 Prostate Cancer Therapeutics Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Prostate Cancer Therapeutics Drugs Industry Trends 13.2 Prostate Cancer Therapeutics Drugs Market Drivers 13.3 Prostate Cancer Therapeutics Drugs Market Challenges 13.4 Prostate Cancer Therapeutics Drugs Market Restraints 14 Key Findings in The Global Prostate Cancer Therapeutics Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryMarket Analysis and Insights: Global Prostate Cancer Therapeutics Drugs Market Table of Contents1 Study Coverage1.1 Prostate Cancer Therapeutics Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Hormone Therapy 1.2.3 Chemotherapy 1.2.4 Biologic Therapy 1.2.5 Targeted Therapy 1.2.6 Other 1.3 Market by Sale Channel 1.3.1 Global Prostate Cancer Therapeutics Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Sales 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Prostate Cancer Therapeutics Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Prostate Cancer Therapeutics Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Prostate Cancer Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Prostate Cancer Therapeutics Drugs Sales by Region 2.4.1 Global Prostate Cancer Therapeutics Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Prostate Cancer Therapeutics Drugs by Region (2023-2028) 2.5 Global Prostate Cancer Therapeutics Drugs Revenue by Region 2.5.1 Global Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2022) 2.5.2 Global Prostate Cancer Therapeutics Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Prostate Cancer Therapeutics Drugs Sales by Manufacturers 3.1.1 Global Top Prostate Cancer Therapeutics Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prostate Cancer Therapeutics Drugs in 2021 3.2 Global Prostate Cancer Therapeutics Drugs Revenue by Manufacturers 3.2.1 Global Prostate Cancer Therapeutics Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Drugs Revenue in 2021 3.3 Global Prostate Cancer Therapeutics Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Prostate Cancer Therapeutics Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Prostate Cancer Therapeutics Drugs Sales by Type 4.1.1 Global Prostate Cancer Therapeutics Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Prostate Cancer Therapeutics Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028) 4.2 Global Prostate Cancer Therapeutics Drugs Revenue by Type 4.2.1 Global Prostate Cancer Therapeutics Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Prostate Cancer Therapeutics Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Prostate Cancer Therapeutics Drugs Price by Type 4.3.1 Global Prostate Cancer Therapeutics Drugs Price by Type (2017-2022) 4.3.2 Global Prostate Cancer Therapeutics Drugs Price Forecast by Type (2023-2028) 5 Market Size by Sale Channel 5.1 Global Prostate Cancer Therapeutics Drugs Sales by Sale Channel 5.1.1 Global Prostate Cancer Therapeutics Drugs Historical Sales by Sale Channel (2017-2022) 5.1.2 Global Prostate Cancer Therapeutics Drugs Forecasted Sales by Sale Channel (2023-2028) 5.1.3 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2028) 5.2 Global Prostate Cancer Therapeutics Drugs Revenue by Sale Channel 5.2.1 Global Prostate Cancer Therapeutics Drugs Historical Revenue by Sale Channel (2017-2022) 5.2.2 Global Prostate Cancer Therapeutics Drugs Forecasted Revenue by Sale Channel (2023-2028) 5.2.3 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2017-2028) 5.3 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel 5.3.1 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2017-2022) 5.3.2 Global Prostate Cancer Therapeutics Drugs Price Forecast by Sale Channel (2023-2028) 6 North America 6.1 North America Prostate Cancer Therapeutics Drugs Market Size by Type 6.1.1 North America Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028) 6.1.2 North America Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028) 6.2 North America Prostate Cancer Therapeutics Drugs Market Size by Sale Channel 6.2.1 North America Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028) 6.2.2 North America Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028) 6.3 North America Prostate Cancer Therapeutics Drugs Market Size by Country 6.3.1 North America Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028) 6.3.2 North America Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Prostate Cancer Therapeutics Drugs Market Size by Type 7.1.1 Europe Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028) 7.1.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028) 7.2 Europe Prostate Cancer Therapeutics Drugs Market Size by Sale Channel 7.2.1 Europe Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028) 7.2.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028) 7.3 Europe Prostate Cancer Therapeutics Drugs Market Size by Country 7.3.1 Europe Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028) 7.3.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Type 8.1.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Sale Channel 8.2.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028) 8.2.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028) 8.3 Asia Pacific Prostate Cancer Therapeutics Drugs Market Size by Region 8.3.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Prostate Cancer Therapeutics Drugs Market Size by Type 9.1.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028) 9.1.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028) 9.2 Latin America Prostate Cancer Therapeutics Drugs Market Size by Sale Channel 9.2.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028) 9.2.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028) 9.3 Latin America Prostate Cancer Therapeutics Drugs Market Size by Country 9.3.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028) 9.3.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Type 10.1.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Sale Channel 10.2.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Sale Channel (2017-2028) 10.2.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Sale Channel (2017-2028) 10.3 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Size by Country 10.3.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Johnson & Johnson 11.1.1 Johnson & Johnson Corporation Information 11.1.2 Johnson & Johnson Overview 11.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Johnson & Johnson Recent Developments 11.2 Pfizer, Inc 11.2.1 Pfizer, Inc Corporation Information 11.2.2 Pfizer, Inc Overview 11.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Pfizer, Inc Recent Developments 11.3 AstraZeneca 11.3.1 AstraZeneca Corporation Information 11.3.2 AstraZeneca Overview 11.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 AstraZeneca Recent Developments 11.4 Amgen, Inc 11.4.1 Amgen, Inc Corporation Information 11.4.2 Amgen, Inc Overview 11.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Amgen, Inc Recent Developments 11.5 AbbVie, Inc 11.5.1 AbbVie, Inc Corporation Information 11.5.2 AbbVie, Inc Overview 11.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 AbbVie, Inc Recent Developments 11.6 Bayer AG 11.6.1 Bayer AG Corporation Information 11.6.2 Bayer AG Overview 11.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Bayer AG Recent Developments 11.7 Ipsen Group 11.7.1 Ipsen Group Corporation Information 11.7.2 Ipsen Group Overview 11.7.3 Ipsen Group Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Ipsen Group Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Ipsen Group Recent Developments 11.8 Sanofi 11.8.1 Sanofi Corporation Information 11.8.2 Sanofi Overview 11.8.3 Sanofi Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Sanofi Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Sanofi Recent Developments 11.9 Endo Pharmaceuticals 11.9.1 Endo Pharmaceuticals Corporation Information 11.9.2 Endo Pharmaceuticals Overview 11.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Endo Pharmaceuticals Recent Developments 11.10 Dendreon Corporation 11.10.1 Dendreon Corporation Corporation Information 11.10.2 Dendreon Corporation Overview 11.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Dendreon Corporation Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Prostate Cancer Therapeutics Drugs Industry Chain Analysis 12.2 Prostate Cancer Therapeutics Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Prostate Cancer Therapeutics Drugs Production Mode & Process 12.4 Prostate Cancer Therapeutics Drugs Sales and Marketing 12.4.1 Prostate Cancer Therapeutics Drugs Sales Channels 12.4.2 Prostate Cancer Therapeutics Drugs Distributors 12.5 Prostate Cancer Therapeutics Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Prostate Cancer Therapeutics Drugs Industry Trends 13.2 Prostate Cancer Therapeutics Drugs Market Drivers 13.3 Prostate Cancer Therapeutics Drugs Market Challenges 13.4 Prostate Cancer Therapeutics Drugs Market Restraints 14 Key Findings in The Global Prostate Cancer Therapeutics Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポートQYResearch 社の最新刊レポート本レポートと同じKEY WORD(prostate cancer)の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/05 10:26 153.43 円 167.28 円 201.52 円 |